Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

We describe herein the synthesis and characterization of a new class of histone deacetylase (HDAC) inhibitors derived from conjugation of a suberoylanilide hydroxamic acid-like aliphatic-hydroxamate pharmacophore to a nuclear localization signal peptide. We found that these conjugates inhibited the histone deacetylase activities of HDACs 1, 2, 6, and 8 in a manner similar to suberoylanilide hydroxamic acid (SAHA). Notably, compound 7b showed a threefold improvement in HDAC 1/2 inhibition, a threefold increase in HDAC 6 selectivity and a twofold increase in HDAC 8 selectivity when compared to SAHA.

Knowledge Graph

Similar Paper

Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide
Bioorganic & Medicinal Chemistry Letters 2009.0
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-Based non-hydroxamates
Bioorganic & Medicinal Chemistry Letters 2003.0
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring
Journal of Medicinal Chemistry 2010.0
Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid
Bioorganic & Medicinal Chemistry Letters 2007.0
Design and synthesis of novel hybrid benzamide–peptide histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Novel Inhibitors of Human Histone Deacetylases:  Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates
Journal of Medicinal Chemistry 2005.0
Design and synthesis of a novel class of histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Design, synthesis and biological evaluation of saccharin-based N -hydroxybenzamides as histone deacetylases (HDACs) inhibitors
Bioorganic & Medicinal Chemistry 2015.0
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C6 position
Bioorganic & Medicinal Chemistry Letters 2012.0